John C. Lin, Vice President of Experimental Medicine at Pfizer will give a featured presentation on “Anti-amyloid Beta in Age-related Macular Degeneration” at the 4th Ocular Diseases and Drug Discovery Conference taking place on February 27-28, 2012 in Las Vegas, NV. Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly, with [...]
Iain Dukes, Vice President, External R&D at Amgen is a Panelist in “Panel Discussion: Trends in Oncology Drug Development” at the Oncology Partnering and Deal-making Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC. Panel Discussion: Trends in Oncology Drug Development Topics to be covered: • Oncology business opportunities for [...]
Denis Patrick, Senior Director & Head, External R&D Innovation, Oncology Research Unit at Pfizer to give a Featured Presentation on “Antibody Drug Conjugation Technology: Past, Present and Future” at the Oncology Partnering and Deal-making Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC. Antibody Drug Conjugation Technology: Past, Present and [...]
Anne Altmeyer, Executive Director, Business Development & Licensing, Oncology, at Novartis is a Panelist in “Panel Discussion: Innovative Partnering & Licensing Strategies” at the Oncology Partnering and Deal-making Conference to be held on February 27-28, 2012 in Las Vegas, NV by GTC. Panel Discussion: Innovative Partnering & Licensing Strategies Topics to be covered: • What [...]
David Woodward, Senior Director of Biological Sciences at Allergan and Barbara Wirostko, Chief Medical Officer at Altheos will give a joint featured presentation entitled “Critical Success Factors in Approving Ophthalmic Drugs: Prostaglandins for Glaucoma/OHT as a Case Study: What Next?” at the 4th Ocular Diseases and Drug Discovery Conference taking place on February 27-28, 2012 [...]
Vincent G. Brichard, Senior Vice President and Head of the Immunotherapeutics Business Unit at GlaxoSmithKline Biologicals will give a keynote presentation on the “Development of Active Immunization against Cancer: The Example of MAGE-A3” at the Immunotherapeutics Partnering and Deal-making Conference to be held in San Diego, CA on January 30-31, 2012 by GTC. Dr. Brichard [...]
Leslie J. Williams, President and CEO at ImmusanT will give a presentation on “ImmusanT’s Development of an Immunotherapeutic Vaccine for Celiac Disease” at the Immunotherapeutics Partnering and Deal-making Conference to be held in San Diego, CA on January 30-31, 2012 by GTC. Celiac Disease is an inherited autoimmune disease triggered by the consumption of foods [...]
Jason Rhodes, Executive Vice President & Chief Business Officer at Epizyme and Michael Shih, Senior Director, Business Development at Eisai will give a featured joint presentation on “Open Innovation: Eisai and Epizyme’s Epigenetics Partnership” at the Oncology Partnering and Deal-making Conference to be held in Las Vegas, NV on February 27-28, 2012 by GTC. Innovation: [...]
Richard Hatchett, Chief Medical Officer and Deputy Director of BARDA and Joseph Larsen, Chief of the Broad Spectrum Antimicrobials (BSA) Program at BARDA will present on “Partnering and Working with BARDA” at the 8th Anti-infectives Partnering and Deal-making Conference to be held in Boston, MA on November 7-8, 2011 by GTC.
Neil S. Ryder, Executive Director of Infectious Diseases at Novartis Institutes for BioMedical Research will give a featured presentation on “Opportunities and Challenges for Novel Antifungal Therapies” at the 8th Anti-infectives Partnering and Deal-making Conference to be held in Boston, MA on November 7-8, 2011 by GTC. Invasive fungal infection is still a major cause [...]